BioBreakthroughs
Trailer
Bonus
Episode 21
Season 1
#21 - Simon Allen, Former CEO of Anebulo Pharmaceuticals
Join us on the latest episode! Our Guest: Simon Allen, Former CEO, Anebulo Pharmaceuticals
What you'll get out of this episode:
- Journey from biochemistry to sell-side biotech business development.
- Current treatment landscape for ACI and the limitations therein.
- Introduction to ANEB-001, a promising antidote aimed at the CB1 receptor to counter cannabinoid overload.
- Impact of synthetic cannabinoids and the silent peril they pose.
- Upcoming milestones: Finalization of Phase 2 data and optimistic outlook towards FDA outcomes.